Background: A case of peritoneal mesothelioma with an anaplastic lymphoma kinase (ALK) translocation was identified, and we conducted further studies to obtain diagnostic and therapeutic insights. We believe that this is the first report describing the cytology of this new tumor type. Case: A teenage woman was referred for severe pleural effusion. Enhanced computed tomography indicated an abdominal mass with ascites. Laparoscopy revealed tumor dissemination from the pelvis to the upper abdomen. Because a high-grade serous carcinoma was suspected, ascitic cytology and biopsy were performed. Cytologically, the tumor displayed characteristics of both adenocarcinoma and reactive or neoplastic mesothelial cells. After extensive pathological evaluation, the tumor was diagnosed as malignant peritoneal mesothelioma. To verify the diagnosis and aid in developing a therapeutic strategy, several companion diagnostics were tried. Surprisingly, the tumor was ALK-positive, and ALK recombination was confirmed by an ALK break-apart test. Retrospectively, cells and tissue specimens were stained with ALK intercalated antibody-enhanced polymer. Tumor cells were clearly distinguished from the nonneoplastic background. Recombination in ALK was reconfirmed by the National Cancer Center Japan, and the patient was enrolled in a clinical trial for alectinib. Conclusion: Companion diagnostics-based cytology may provide a useful means of monitoring and evaluating a molecular-targeted therapy.

1.
Sawyers
CL
. Kinase inhibitors as anticancer drugs. In:
Devita
VT
,
Lawrence
TS
,
Rosenberg
SA
, editors
.
Cancer: principles and practice of oncology. Primer of the molecular biology of cancer
. 2nd ed.
Philadelphia
:
Wolters Kluwer
;
2015
. pp.
106
21
.
2.
Kohno
T
.
Implementation of “clinical sequencing” in cancer genome medicine in Japan
.
Cancer Sci
.
2018
Mar
;
109
(
3
):
507
12
.
[PubMed]
1347-9032
3.
Loharamtaweethong
K
,
Puripat
N
,
Aoonjai
N
,
Sutepvarnon
A
,
Bandidwattanawong
C
.
Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum
.
Histopathology
.
2016
Mar
;
68
(
4
):
603
7
.
[PubMed]
0309-0167
4.
Hung
YP
,
Dong
F
,
Watkins
JC
,
Nardi
V
,
Bueno
R
,
Dal Cin
P
, et al.
Identification of ALK rearrangements in malignant peritoneal mesothelioma
.
JAMA Oncol
.
2018
Feb
;
4
(
2
):
235
8
.
[PubMed]
2374-2437
5.
JMACCT [Internet]. Tokyo: Investigator-initiated clinical trial of alectinib in patient with ALK positive rare cacer (TACKLE). [cited 2019 May 2]. Available from: https://dbcentre3.jmacct.med.or.jp/JMACTR/App/JMACTRE02_04/JMACTRE02_04.aspx?kbn=3&seqno=8259
6.
Hjerpe
A
,
Ascoli
V
,
Bedrossian
CW
,
Boon
ME
,
Creaney
J
,
Davidson
B
, et al.;
International Mesothelioma Interest Group
;
International Academy of Cytology
.
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: complementary statement from the international mesothelioma interest group, also endorsed by the international academy of cytology and the papanicolaou society of cytopathology
.
Diagn Cytopathol
.
2015
Jul
;
43
(
7
):
563
76
.
[PubMed]
8755-1039
7.
Husain
AN
,
Colby
TV
,
Ordóñez
NG
,
Allen
TC
,
Attanoos
RL
,
Beasley
MB
, et al.
Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group
.
Arch Pathol Lab Med
.
2018
Jan
;
142
(
1
):
89
108
.
[PubMed]
0003-9985
8.
Shanks
JH
,
Harris
M
,
Banerjee
SS
,
Eyden
BP
,
Joglekar
VM
,
Nicol
A
, et al.
Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females
.
Am J Surg Pathol
.
2000
Feb
;
24
(
2
):
285
94
.
[PubMed]
0147-5185
9.
Ordóñez
NG
.
Deciduoid mesothelioma: report of 21 cases with review of the literature
.
Mod Pathol
.
2012
Nov
;
25
(
11
):
1481
95
.
[PubMed]
0893-3952
10.
Oczypok
EA
,
Oury
TD
.
Electron microscopy remains the gold standard for the diagnosis of epithelial malignant mesothelioma: a case study
.
Ultrastruct Pathol
.
2015
Apr
;
39
(
2
):
153
8
.
[PubMed]
0191-3123
11.
Ordóñez
NG
.
The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study
.
Mod Pathol
.
2006
Jan
;
19
(
1
):
34
48
.
[PubMed]
0893-3952
12.
Munkholm-Larsen
S
,
Cao
CQ
,
Yan
TD
.
Malignant peritoneal mesothelioma
.
World J Gastrointest Surg
.
2009
Nov
;
1
(
1
):
38
48
.
[PubMed]
1948-9366
13.
Haber
SE
,
Haber
JM
.
Malignant mesothelioma: a clinical study of 238 cases
.
Ind Health
.
2011
;
49
(
2
):
166
72
.
[PubMed]
0019-8366
14.
Baker
PM
,
Clement
PB
,
Young
RH
.
Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis
.
Am J Clin Pathol
.
2005
May
;
123
(
5
):
724
37
.
[PubMed]
0002-9173
15.
Mani
H
,
Merino
MJ
.
Mesothelial neoplasms presenting as, and mimicking, ovarian cancer
.
Int J Gynecol Pathol
.
2010
Nov
;
29
(
6
):
523
8
.
[PubMed]
0277-1691
16.
Duan
HJ
,
Itoh
N
,
Yamagami
O
,
Katsuyama
T
,
Shigematsu
H
.
Diffuse malignant peritoneal mesothelioma in a young woman with a high serum level of CA125
.
Acta Pathol Jpn
.
1991
Feb
;
41
(
2
):
158
63
.
[PubMed]
0001-6632
17.
Niggli
FK
,
Gray
TJ
,
Raafat
F
,
Stevens
MC
.
Spectrum of peritoneal mesothelioma in childhood: clinical and histopathologic features, including DNA cytometry
.
Pediatr Hematol Oncol
.
1994
Jul-Aug
;
11
(
4
):
399
408
.
[PubMed]
0888-0018
18.
Thomas
A
,
Chen
Y
,
Yu
T
,
Gill
A
,
Prasad
V
.
Distinctive clinical characteristics of malignant mesothelioma in young patients
.
Oncotarget
.
2015
Jun
;
6
(
18
):
16766
73
.
[PubMed]
1949-2553
19.
Mönch
D
,
Bode-Erdmann
S
,
Kalla
J
,
Sträter
J
,
Schwänen
C
,
Falkenstern-Ge
R
, et al.
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy
.
Oncotarget
.
2018
Apr
;
9
(
29
):
20781
94
.
[PubMed]
1949-2553
20.
Tandon
RT
,
Jimenez-Cortez
Y
,
Taub
R
,
Borczuk
AC
.
Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases
.
Arch Pathol Lab Med
.
2018
Feb
;
142
(
2
):
236
42
.
[PubMed]
0003-9985
21.
Bubendorf
L
. Chapter 7: ALK analysis in cytology. In:
Hirsch
FR
,
Yatabe
Y
, editors
.
IASLC Atlas of ALK testing in lung cancer. Colorado: International association of the study of lung cancer
.
Tsao (MS)
;
2013
. pp.
53
7
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.